Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Berenbaum

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
The Journal of Antimicrobial Chemotherapy|February 1, 1987
Minor synergy and antagonism may be clinically importantM C Berenbaum
Lancet (London, England)|February 7, 1987
Intrathecal interferon, indomethacin, and multiple sclerosisM C Berenbaum
The Journal of Infectious Diseases|February 1, 1978
A method for testing for synergy with any number of agentsM C Berenbaum
Immunology|February 1, 1979
Time-dependence and selectivity of immunosuppressive agentsM C Berenbaum
Chemotherapy|January 1, 1979
The immunosuppressive effects of 5-fluorocytosine and 5-fluorouracilM C Berenbaum
Proceedings of the Royal Society of Medicine|October 1, 1970
The mode of action of cytotoxic drugsM C Berenbaum
Lancet (London, England)|November 9, 1974
Letter: Predicting response of human cancer to chemotherapyM C Berenbaum
The Journal of Infectious Diseases|September 1, 1980
Correlations between methods for measurement of synergyM C Berenbaum
The Journal of Infectious Diseases|August 1, 1984
Synergy assessment with growth curvesM C Berenbaum
British Journal of Cancer|January 1, 1990
Direct search methods in the optimisation of cancer chemotherapy regimensM C Berenbaum
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|February 1, 1987
Minor synergy and antagonism may be clinically importantM C Berenbaum
Lancet (London, England)|February 7, 1987
Intrathecal interferon, indomethacin, and multiple sclerosisM C Berenbaum
The Journal of Infectious Diseases|February 1, 1978
A method for testing for synergy with any number of agentsM C Berenbaum
Immunology|February 1, 1979
Time-dependence and selectivity of immunosuppressive agentsM C Berenbaum
Chemotherapy|January 1, 1979
The immunosuppressive effects of 5-fluorocytosine and 5-fluorouracilM C Berenbaum
Proceedings of the Royal Society of Medicine|October 1, 1970
The mode of action of cytotoxic drugsM C Berenbaum
Lancet (London, England)|November 9, 1974
Letter: Predicting response of human cancer to chemotherapyM C Berenbaum
The Journal of Infectious Diseases|September 1, 1980
Correlations between methods for measurement of synergyM C Berenbaum
The Journal of Infectious Diseases|August 1, 1984
Synergy assessment with growth curvesM C Berenbaum
British Journal of Cancer|January 1, 1990
Direct search methods in the optimisation of cancer chemotherapy regimensM C Berenbaum
Pageof 6